Skip to content

Clinical trials

Phase 3 Stomach Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 3 Country / region: United Kingdom Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20082
20092
20101
20112
20122
20141
20151
20162
20172
20184
20212
20222
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting5
Terminated4
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche3
Merck Sharp & Dohme LLC3
Amgen2
Astellas Pharma Global Development, Inc.2
AstraZeneca2
Daiichi Sankyo2
Eli Lilly and Company2
Taiho Oncology, Inc.2
Arcus Biosciences, Inc.1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms29
Adenocarcinoma6
Esophageal Neoplasms3
Neoplasms3
Neoplasm Metastasis2
Digestive System Neoplasms1
Nausea1
Pain1
Stomach Diseases1
Vomiting1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.